Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Boehringer Ingelheim unit Bedford Labs recalling cancer drug cytarabine
Yahoo/AP
Friday, March 9, 2012 - 10:44am
tags:
Bedford Labs, Boehringer Ingelheim, recalls, cancer, cytarabine
DepoMed Beats on Both Top and Bottom Lines
Motley Fool
Friday, March 9, 2012 - 10:40am
tags:
Depomed, earnings
Weight loss drug developer Orexigen posts smaller 4th-quarter loss as costs decrease
Yahoo/AP
Friday, March 9, 2012 - 10:39am
tags:
earnings, Orexigen
Checking an Important Metric at Allergan
Motley Fool
Friday, March 9, 2012 - 10:39am
tags:
Allergan
AstraZeneca citizen petitions on Quetiapine labeling receives FDA response
Yahoo/Fly on the Wall
Friday, March 9, 2012 - 10:31am
tags:
AstraZeneca, FDA, Quetiapine, generics, Seroquel
Merck's hepatitis C drug wins UK cost endorsement
Reuters
Friday, March 9, 2012 - 10:29am
tags:
Merck, UK, hepatitis C, Victrelis
Bellicum snags $20M for mid-stage cancer vaccine program
Fierce Biotech
Thursday, March 8, 2012 - 3:33pm
tags:
BPX-101, prostate cancer, Bellicum
U.S. could bring more common drugs over the counter
Reuters
Thursday, March 8, 2012 - 3:26pm
tags:
OTC, FDA
AIDS Cure Quest Advances as Merck Cancer Drug Attacks Hidden HIV
Bloomberg
Thursday, March 8, 2012 - 3:23pm
tags:
AIDS, Merck, HIV, Zolinza
J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation
TheStreet.com
Thursday, March 8, 2012 - 10:15am
tags:
JNJ, prostate cancer, Dendreon, Provenge, Medivation, Zytiga, MDV3100
Optimer Pharmaceuticals Whiffs on Earnings
Motley Fool
Thursday, March 8, 2012 - 10:14am
tags:
Optimer Pharmaceuticals
Sequenom Meets on Revenues, Misses on EPS
Motley Fool
Thursday, March 8, 2012 - 10:13am
tags:
earnings, Sequenom
The Age Of Personalized Medicine Has Arrived
Seeking Alpha
Thursday, March 8, 2012 - 10:12am
tags:
personalized medicine, Nektar, Life Technologies, Threshold Pharmaceuticals
Celgene completes acquisition of Avila Therapeutics
Yahoo/Fly on the Wall
Thursday, March 8, 2012 - 10:11am
tags:
Celgene, M&A, Avila
Zalicus May Be 2012's 'Come Back Kid' Biotech Stock
Seeking Alpha
Thursday, March 8, 2012 - 10:00am
tags:
Zalicus, Z160, Keryx, Aeterna Zentaris
NeurogesX Fails to Win U.S. Approval to Sell Patch for HIV-Related Pain
Bloomberg
Thursday, March 8, 2012 - 9:59am
tags:
FDA, HIV, NeurogesX, HIV-related pain, Qutenza
Radiation Blast May Turbocharge Bristol-Myers Melanoma Drug, Report Shows
Bloomberg
Thursday, March 8, 2012 - 9:57am
tags:
melanoma, Bristol-Myers Squibb, radiation therapy, Yervoy
AZN's FluMist Quadrivalent Approved
Yahoo/Zacks
Thursday, March 8, 2012 - 9:56am
tags:
AstraZeneca, FluMist Quadrivalent, Flu
Study finds Aricept still helps when Alzheimer's patients progress to moderate-to-severe stage
Yahoo/AP
Thursday, March 8, 2012 - 9:56am
tags:
Aricept, Alzheimer's disease, Pfizer, Lundbeck, Namenda
U.S. Regulators Probes Resuming Painkiller Trials Tied to Joint Failure
Bloomberg
Thursday, March 8, 2012 - 9:55am
tags:
Pfizer, JNJ, FDA, joint failure, painkillers, fulranumab, Sanofi, Regeneron, tanezumab, REGN475/SAR164877

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.